Novavax Debt-to-Equity Ratio Growth & History (NVAX)
Novavax's debt-to-equity ratio was 0.49 for fiscal 2020.
View full Novavax company overviewNovavax annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2020 | 2020-12-31 | 0.49 | — | — |
| 2015 | 2015-12-31 | 0.00 | −0.00 | −48.61% |
| 2014 | 2014-12-31 | 0.00 | −0.00 | −54.77% |
| 2013 | 2013-12-31 | 0.01 | 0.00 | +57.93% |
| 2012 | 2012-12-31 | 0.00 | — | — |
Novavax quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2025 | 2025-06-30 | 1.54 | — | — |
| Q1 2022 | 2022-03-31 | 6.74 | 6.61 | +4983.52% |
| Q3 2021 | 2021-09-30 | 0.23 | −0.93 | −80.47% |
| Q2 2021 | 2021-06-30 | 0.14 | — | — |
| Q1 2021 | 2021-03-31 | 0.13 | — | — |
| Q4 2020 | 2020-12-31 | 0.49 | — | — |
| Q3 2020 | 2020-09-30 | 1.15 | — | — |
| Q4 2015 | 2015-12-31 | 0.00 | −0.00 | −48.61% |
| Q4 2014 | 2014-12-31 | 0.00 | −0.00 | −54.77% |
| Q3 2014 | 2014-09-30 | 0.00 | −0.00 | −41.30% |
| Q2 2014 | 2014-06-30 | 0.00 | −0.00 | −75.15% |
| Q1 2014 | 2014-03-31 | 0.00 | −0.00 | −57.23% |
| Q4 2013 | 2013-12-31 | 0.01 | 0.00 | +57.93% |
| Q3 2013 | 2013-09-30 | 0.00 | −0.00 | −69.09% |
| Q2 2013 | 2013-06-30 | 0.00 | — | — |
| Q1 2013 | 2013-03-31 | 0.00 | — | — |
| Q4 2012 | 2012-12-31 | 0.00 | — | — |
| Q3 2012 | 2012-09-30 | 0.01 | — | — |
Novavax debt-to-equity ratio trends
Over the last five fiscal years, Novavax's debt-to-equity ratio increased from 0.00 to 0.49, a change of 0.49. The latest reported quarter, Q2 2025, shows 1.54.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Novavax source filings ↗